Toxicological Reviews

, Volume 24, Issue 2, pp 93–106 | Cite as

Poisoning due to Pyrethroids

  • Sally M. Bradberry
  • Sarah A. Cage
  • Alex T. Proudfoot
  • J. Allister Vale
Review Article


The first pyrethroid pesticide, allethrin, was identified in 1949. Allethrin and other pyrethroids with a basic cyclopropane carboxylic ester structure are type I pyrethroids. The insecticidal activity of these synthetic pyrethroids was enhanced further by the addition of a cyano group to give α-cyano (type II) pyrethroids, such as cypermethrin. The finding of insecticidal activity in a group of phenylacetic 3-phenoxybenzyl esters, which lacked the cyclopropane ring but contained the α-cyano group (and hence were type II pyrethroids) led to the development of fenvalerate and related compounds. All pyrethroids can exist as at least four stereoisomers, each with different biological activities. They are marketed as racemic mixtures or as single isomers. In commercial formulations, the activity of pyrethroids is usually enhanced by the addition of a synergist such as piperonyl butoxide, which inhibits metabolic degradation of the active ingredient. Pyrethroids are used widely as insecticides both in the home and commercially, and in medicine for the topical treatment of scabies and headlice. In tropical countries mosquito nets are commonly soaked in solutions of deltamethrin as part of antimalarial strategies.

Pyrethroids are some 2250 times more toxic to insects than mammals because insects have increased sodium channel sensitivity, smaller body size and lower body temperature. In addition, mammals are protected by poor dermal absorption and rapid metabolism to non-toxic metabolites. The mechanisms by which pyrethroids alone are toxic are complex and become more complicated when they are co-formulated with either piperonyl butoxide or an organophosphorus insecticide, or both, as these compounds inhibit pyrethroid metabolism. The main effects of pyrethroids are on sodium and chloride channels. Pyrethroids modify the gating characteristics of voltage-sensitive sodium channels to delay their closure. A protracted sodium influx (referred to as a sodium ‘tail current’) ensues which, if it is sufficiently large and/or long, lowers the action potential threshold and causes repetitive firing; this may be the mechanism causing paraesthesiae. At high pyrethroid concentrations, the sodium tail current may be sufficiently great to prevent further action potential generation and ‘conduction block’ ensues. Only low pyrethroid concentrations are necessary to modify sensory neurone function. Type II pyrethroids also decrease chloride currents through voltage-dependent chloride channels and this action probably contributes the most to the features of poisoning with type II pyrethroids. At relatively high concentrations, pyrethroids can also act on GABA-gated chloride channels, which may be responsible for the seizures seen with severe type II poisoning.

Despite their extensive world-wide use, there are relatively few reports of human pyrethroid poisoning. Less than ten deaths have been reported from ingestion or following occupational exposure. Occupationally, the main route of pyrethroid absorption is through the skin. Inhalation is much less important but increases when pyrethroids are used in confined spaces. The main adverse effect of dermal exposure is paraesthesiae, presumably due to hyperactivity of cutaneous sensory nerve fibres. The face is affected most commonly and the paraesthesiae are exacerbated by sensory stimulation such as heat, sunlight, scratching, sweating or the application of water.

Pyrethroid ingestion gives rise within minutes to a sore throat, nausea, vomiting and abdominal pain. There may be mouth ulceration, increased secretions and/or dysphagia. Systemic effects occur 4–8 hours after exposure. Dizziness, headache and fatigue are common, and palpitations, chest tightness and blurred vision less frequent. Coma and convulsions are the principal life-threatening features. Most patients recover within 6 days, although there were seven fatalities among 573 cases in one series and one among 48 cases in another.

Management is supportive. As paraesthesiae usually resolve in 12–24 hours, specific treatment is not generally required, although topical application of dl-α tocopherol acetate (vitamin E) may reduce their severity.


Ivermectin Cypermethrin Scabies Fenvalerate Dermal Exposure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the contents of this review.


  1. 1.
    Aldridge WN, Clothier B, Forshaw P, et al. The effect of DDT and the pyrethroid cismethrin and decamethrin on the acetyl choline and cyclic nucleotide content of rat brain. Biochem Pharmacol 1978; 27: 1703–6PubMedCrossRefGoogle Scholar
  2. 2.
    Kumar S, Thomas A, Sahgal A, et al. Variations in the insecticide-resistance spectrum of Anopheles stephensi after selection with deltamethrin or a deltamethrin-piperonyl-butoxide combination. Ann Trop Med Parasitol 2004; 98: 861–71PubMedCrossRefGoogle Scholar
  3. 3.
    Barlow SM, Sullivan FM, Lines J. Risk assessment of the use of deltamethrin on bednets for the prevention of malaria. Food Chem Toxicol 2001; 39: 407–22PubMedCrossRefGoogle Scholar
  4. 4.
    He F, Wang S, Liu L, et al. Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol 1989; 63: 54–8PubMedCrossRefGoogle Scholar
  5. 5.
    Peter JV, John G, Cherian AM. Pyrethroid poisoning. J Assoc Physicians India 1996; 44: 343–4PubMedGoogle Scholar
  6. 6.
    Litovitz TL, Klein-Schwartz W, Rodgers GC, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2002; 20: 391–452PubMedCrossRefGoogle Scholar
  7. 7.
    Watson WA, Litovitz TL, Rodgers GC, et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21: 353–421PubMedCrossRefGoogle Scholar
  8. 8.
    Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2004; 22: 335–404PubMedCrossRefGoogle Scholar
  9. 9.
    Ray DE. Toxicology of pyrethrins and synthetic pyrethroids. In: Marrs TC, Ballantyne B, editors. Pesticide toxicology and international regulation. Chichester: John Wiley & Sons, 2004: 129–58Google Scholar
  10. 10.
    Narahashi T, Carter DB, Frey J, et al. Sodium channels and GABAA receptor-channel complex as targets of environmental toxicants. Toxicol Lett 1995; 82–83: 239–45PubMedCrossRefGoogle Scholar
  11. 11.
    Narahashi T. Neuronal ion channels as the target sites of insecticides. Pharmacol Toxicol 1996; 78: 1–14CrossRefGoogle Scholar
  12. 12.
    Song J-H, Narahashi T. Modulation of sodium channels of rat cerebellar Purkinje neurons by the pyrethroid tetramethrin. J Pharmacol Exp Ther 1996; 277: 445–53PubMedGoogle Scholar
  13. 13.
    Bradbury SP, Coats JR. Comparative toxicology of the pyrethroid insecticides. Rev Environ Contam Toxicol 1989; 108: 133–77PubMedCrossRefGoogle Scholar
  14. 14.
    Hodgson E, Levi PE. Interactions of piperonyl butoxide with cytochrome P450. In: Glynne Jones D, editor. Piperonyl butoxide. London: Academic Press, 1999: 41–53CrossRefGoogle Scholar
  15. 15.
    Hutson DH. The metabolic fate of synthetic pyrethroid insecticides in mammals. In: Bridges JW, Chasseaud LF, editors. Progress in drug metabolism. New York: John Wiley & Sons, 1979: 215–52Google Scholar
  16. 16.
    Abou-Donia MB, Wilmarth KR, Jensen KF, et al. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health 1996; 48: 35–56PubMedCrossRefGoogle Scholar
  17. 17.
    He F, Zhang Z, Chen S, et al. Effects of combined exposure to pyrethroids and methamidophos on sprayers. Arch Complex Environ Stud 1990; 2: 31–6Google Scholar
  18. 18.
    Narahashi T. The role of ion channels in insecticide action. In: Narahashi T, Chambers JE, editors. Insecticide action: from molecule to organism. New York: Plenum Press, 1989: 55–84CrossRefGoogle Scholar
  19. 19.
    Eells JT, Bandettini PA, Holman PA, et al. Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential. J Pharmacol Exp Ther 1992; 262: 1173–81PubMedGoogle Scholar
  20. 20.
    Vijverberg HPM, van den Bercken J. Action of pyrethroid insecticides on the vertebrate nervous system. Neuropathol Appl Neurobiol 1982; 8: 421–40PubMedCrossRefGoogle Scholar
  21. 21.
    Soderlund DM, Bloomquist JR. Neurotoxic actions of pyrethroid insecticides. Annu Rev Entomol 1989; 34: 77–96PubMedCrossRefGoogle Scholar
  22. 22.
    Miyamoto J, Kaneko H, Tsuji R, et al. Pyrethroids, nerve poisons: how their risks to human health should be assessed. Toxicol Lett 1995; 82–83: 933–40PubMedCrossRefGoogle Scholar
  23. 23.
    Clark JM, Brooks MW. Neurotoxicology of pyrethroids: single or multiple mechanisms of action? Environ Toxicol Chem 1989; 8: 361–72Google Scholar
  24. 24.
    Song J-H, Nagata K, Tatebayashi H, et al. Interactions of tetramethrin, fenvalerate and DDT at the sodium channel in rat dorsal root ganglion neurons. Brain Res 1996; 708: 29–37PubMedCrossRefGoogle Scholar
  25. 25.
    Forshaw PJ, Ray DE. A novel action of deltamethrin on membrane resistance in mammalian skeletal muscle and non-myelinated nerve fibres. Neuropharmacology 1990; 29: 71–81PubMedCrossRefGoogle Scholar
  26. 26.
    Forshaw PJ, Ray DE. A voltage-dependent chloride channel in NIE115 neuroblastoma-cells is activated by protein-kinase-c and also by the pyrethroid deltamethrin [abstract]. J Physiol 1993; 467: 252Google Scholar
  27. 27.
    Ray DE, Sutharsan S, Forshaw PJ. Actions of pyrethroid insecticides on voltage-gated chloride channels in neuroblastoma cells. Neurotoxicology 1997; 18: 755–60PubMedGoogle Scholar
  28. 28.
    Forshaw PJ, Lister T, Ray DE. The role of voltage-gated chloride channels in type II pyrethroid insecticide poisoning. Toxicol Appl Pharmacol 2000; 163: 1–8PubMedCrossRefGoogle Scholar
  29. 29.
    Bloomquist JR, Adams PM, Soderlund DM. Inhibition of gamma-aminobutyric acid-stimulated chloride flux in mouse brain vesicles by polychlorocycloalkane and pyrethroid insecticides. Neurotoxicology 1986; 7: 11–20PubMedGoogle Scholar
  30. 30.
    Bradbury JE, Forshaw PJ, Gray AJ, et al. The action of mephenesin and other agents on the effects produced by two neurotoxic pyrethroids in the intact and spinal rat. Neuropharmacology 1983; 22: 907–14PubMedCrossRefGoogle Scholar
  31. 31.
    Joy RM, Albertson TE. Interactions of GABAA antagonists with deltamethrin, diazepam, pentobarbital, and SKF100330A in the rat dentate gyrus. Toxicol Appl Pharmacol 1991; 109: 251–62PubMedCrossRefGoogle Scholar
  32. 32.
    Cremer JE, Cunningham VJ, Ray DE, et al. Regional changes in brain glucose utilization in rats given a pyrethroid insecticide. Brain Res 1980; 194: 278–82PubMedCrossRefGoogle Scholar
  33. 33.
    Gammon DW, Lawrence LJ, Casida JE. Pyrethroid toxicology: protective effects of diazepam and phenobarbital in the mouse and the cockroach. Toxicol Appl Pharmacol 1982; 66: 290–6PubMedCrossRefGoogle Scholar
  34. 34.
    Devaud LL, Szot P, Murray TF. PK 11195 antagonism of pyrethroid-induced proconvulsant activity. Eur J Pharmacol 1986; 121: 269–73PubMedCrossRefGoogle Scholar
  35. 35.
    Cremer JE, Seville MP. Comparative effect of two pyrethroids, deltamethrin and cismethrin on plasma catecholamines and on blood glucose and lactate. Toxicol Appl Pharmacol 1982; 66: 124–33PubMedCrossRefGoogle Scholar
  36. 36.
    Cremer JE, Ray DE, Sarna GS, et al. A study of the kinetic behaviour of glucose based on simultaneous estimates of influx and phosphorylation in brain regions of rats in different physiological states. Brain Res 1981; 221: 331–42PubMedCrossRefGoogle Scholar
  37. 37.
    Husain R, Husain RA, Adhami VM, et al. Behavioral, neurochemical, and neuromorphological effects of deltamethrin in adult rats. J Toxicol Environ Health 1996; 48: 515–26PubMedCrossRefGoogle Scholar
  38. 38.
    Ray DE, Forshaw PJ. Pyrethroid insecticides: poisoning syndromes, synergies, and therapy. J Toxicol Clin Toxicol 2000; 38: 95–101PubMedCrossRefGoogle Scholar
  39. 39.
    Ray DE. The contrasting actions of two pyrethroids (deltamethrin and cismethrin) in the rat. Neurobehav Toxicol Teratol 1982; 4: 801–4PubMedGoogle Scholar
  40. 40.
    Brodie ME, Aldridge WN. Elevated cerebellar cyclic gpm levels during the deltamethrin-induced motor syndrome. Neurobehav Toxicol Teratol 1982; 4: 109–13PubMedGoogle Scholar
  41. 41.
    Dorman DC, Beasley VR. Neurotoxicology of pyrethrin and the pyrethroid insecticides. Vet Hum Toxicol 1991; 33: 238–43PubMedGoogle Scholar
  42. 42.
    Nassif M, Brooke JP, Hutchinson DBA, et al. Studies with permethrin against bodylice in Egypt. Pestic Sci 1980; 11: 679–84CrossRefGoogle Scholar
  43. 43.
    Eadsforth CV, Bragt PC, van Sittert NJ. Human dose-excretion studies with pyrethroid insecticides cypermethrin and alphacypermethrin: relevance for biological monitoring. Xenobiotica 1988; 18: 603–14PubMedCrossRefGoogle Scholar
  44. 44.
    Woollen BH, Marsh JR, Chester G. Metabolite profiles of a pyrethroid insecticide following oral and dermal absorption in man. In: Proceedings of a Conference on Percutaneous Penetration; 1991 Apr 10–12, 20–5Google Scholar
  45. 45.
    Woollen BH, Marsh JR, Laird WJD, et al. The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration. Xenobiotica 1992; 22: 983–91PubMedCrossRefGoogle Scholar
  46. 46.
    Chester G, Sabapathy NN, Woollen BH. Exposure and health assessment during application of lambda-cyhalothrin for malaria vector control in Pakistan. Bull World Health Organ 1992; 70: 615–9PubMedGoogle Scholar
  47. 47.
    Bast GE, Taeschner D, Kampffmeyer HG. Permethrin absorption not detected in single-pass perfused rabbit ear, and absorption with oxidation of 3-phenox-ybenzyl alcohol. Arch Toxicol 1997; 71: 179–86PubMedCrossRefGoogle Scholar
  48. 48.
    Gotoh Y, Kawakami M, Matsumoto N, et al. Permethrin emulsion ingestion: clinical manifestations and clearance of isomers. J Toxicol Clin Toxicol 1998; 36: 57–61PubMedCrossRefGoogle Scholar
  49. 49.
    Selim S, Preiss FJ, Gabriel KL, et al. Absorption and mass balance of piperonyl butoxide following an 8-h dermal exposure in human volunteers. Toxicol Lett 1999; 107: 207–17PubMedCrossRefGoogle Scholar
  50. 50.
    Wester RC, Bucks DAW, Maibach HI. Human in vivo percutaneous absorption of pyrethrin and piperonyl butoxide. Food Chem Toxicol 1994; 32: 51–3PubMedCrossRefGoogle Scholar
  51. 51.
    Kamienski FX, Casida JE. Importance of demethylenation in the metabolism in vivo and in vitro of methylenedioxyphenyl synergists and related compounds in mammals. Biochem Pharmacol 1970; 19: 91–112PubMedCrossRefGoogle Scholar
  52. 52.
    Ray DE. Pesticides derived from plants and other organisms. 13.2 Pyrethrum and related compounds. In: Hayes Jr WJ, Laws Jr ER, editors. Handbook of pesticide toxicology. San Diego (CA): Academic Press, 1991: 585–636Google Scholar
  53. 53.
    Kaneko H, Miyamoto J. Pyrethroid chemistry and metabolism. In: Krieger RI, editor. Handbook of pesticide toxicology. 2nd ed. San Diego (CA): Academic Press, 2001: 1263–88CrossRefGoogle Scholar
  54. 54.
    Leahey JP. Metabolism and environmental degradation. In: Leahey JP, editor. The pyrethroid insecticides. London: Taylor & Francis, 1985: 263–342Google Scholar
  55. 55.
    Soderlund DM, Casida JE. Effects of pyrethroid structure on rates of hydrolysis and oxidation by mouse liver microsomal enzymes. Pestic Biochem Physiol 1977; 7: 391–401CrossRefGoogle Scholar
  56. 56.
    Kinsler S, Levi PE, Hodgson E. Relative contributions of the cytochrome P450 and flavin-containing monooxygenases to the microsomal oxidation of phorate following treatment of mice with phenobarbital, hydrocortisone, acetone, and piperonyl butoxide. Pestic Biochem Physiol 1990; 37: 174–81CrossRefGoogle Scholar
  57. 57.
    Dalvi RR, Dalvi PS. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats. Drug Chem Toxicol 1991; 14: 219–29PubMedCrossRefGoogle Scholar
  58. 58.
    Conney AH, Chang R, Levin WM, et al. Effects of piperonyl butoxide on drug metabolism in rodents and man. Arch Environ Health 1972; 24: 97–107PubMedGoogle Scholar
  59. 59.
    Krieger RI, editor. Handbook of pesticide toxicology. Vol. 2, agents. 2nd ed. San Diego (CA): Academic Press, 2001Google Scholar
  60. 60.
    Zhang Z, Sun J, Chen S, et al. Levels of exposure and biological monitoring of pyrethroids in spraymen. Br J Ind Med 1991; 48: 82–6PubMedGoogle Scholar
  61. 61.
    van der Rhee HJ, Farquhar JA, Vermeulen NPE. Efficacy and transdermal absorption of permethrin in scabies patients. Acta Derm Venereol 1989; 69: 170–82PubMedGoogle Scholar
  62. 62.
    Eadsforth CV, Baldwin MK. Human dose-excretion studies with the pyrethroid insecticide, cypermethrin. Xenobiotica 1983; 13: 67–72PubMedCrossRefGoogle Scholar
  63. 63.
    He F, Sun J, Han K, et al. Effects of pyrethroid insecticides on subjects engaged in packaging pyrethroids. Br J Ind Med 1988; 45: 548–51PubMedGoogle Scholar
  64. 64.
    He F, Deng H, Ji X, et al. Changes of nerve excitability and urinary deltamethrin in sprayers. Int Arch Occup Environ Health 1991; 62: 587–90PubMedCrossRefGoogle Scholar
  65. 65.
    International Programme on Chemical Safety. Environmental health criteria 82. Cypermethrin. Geneva: World Health Organization, 1989Google Scholar
  66. 66.
    Asakawa F, Jitsunari F, Miki K, et al. Agricultural worker exposure to and absorption of permethrin applied to cabbage. Bull Environ Contain Toxicol 1996; 56: 42–9CrossRefGoogle Scholar
  67. 67.
    Leng G, Kühn KH, Idel H. Biological monitoring of pyrethroid metabolites in urine of pest control operators. Toxicol Lett 1996; 88: 215–20PubMedCrossRefGoogle Scholar
  68. 68.
    Anadón A, Martinez-Larrañaga MR, Fernandez-Cruz ML, et al. Toxicokinetics of deltamethrin and its 4′-HO-metabolite in the rat. Toxicol Appl Pharmacol 1996; 141:8–16PubMedGoogle Scholar
  69. 69.
    Gray AJ, Connors TA, Hoellinger H, et al. The relationship between the pharmacokinetics of intravenous cismethrin and bioresmethrin and their mammalian toxicity. Pestic Biochem Physiol 1980; 13: 281–93CrossRefGoogle Scholar
  70. 70.
    FAO/WHO. Pesticide residues in food: evaluations 1999. Part II: toxicological. Geneva: WHO/PCS, 2000Google Scholar
  71. 71.
    FAO/WHO. Pesticide residues in food: evaluations 2000. Part II: toxicological. Geneva: WHO/PCS, 2001Google Scholar
  72. 72.
    Adamis Z, Antal A, Füzesi I, et al. Occupational exposure to organophosphorus insecticides and synthetic pyrethroid. Int Arch Occup Environ Health 1985; 56: 299–305PubMedCrossRefGoogle Scholar
  73. 73.
    Chen S, Zhang Z, He F, et al. An epidemiological study on occupational acute pyrethroid poisoning in cotton farmers. Br J Ind Med 1991; 48: 77–81PubMedGoogle Scholar
  74. 74.
    Llewellyn DM, Brazier A, Brown R, et al. Occupational exposure to permethrin during its use as a public hygiene insecticide. Ann Occup Hyg 1996; 40: 499–509PubMedGoogle Scholar
  75. 75.
    Chester G, Hatfield LD, Hart TB, et al. Worker exposure to, and absorption of cypermethrin during aerial application of an ‘ultra low volume’ formulation to cotton. Arch Environ Contam Toxicol 1987; 16: 69–78PubMedCrossRefGoogle Scholar
  76. 76.
    Altenkirch H, Hopmann D, Brockmeier B, et al. Neurological investigations in 23 cases of pyrethroid intoxication reported to the German Federal Health Office. Neurotoxicology 1996; 17: 645–51PubMedGoogle Scholar
  77. 77.
    Wilkes MF. Pyrethroid-induced paresthesia: a central or local toxic effect? J Toxicol Clin Toxicol 2000; 38: 103–5CrossRefGoogle Scholar
  78. 78.
    Aldridge WN. An assessment of the toxicological properties of pyrethroids and their neurotoxicity. Crit Rev Toxicol 1990; 21: 89–104PubMedCrossRefGoogle Scholar
  79. 79.
    Tucker SB, Flannigan SA, Smolensky MH. Comparison of therapeutic agents for synthetic pyrethroid exposure. Contact Dermatitis 1983; 9: 316PubMedCrossRefGoogle Scholar
  80. 80.
    Knox JM, Tucker SB. A new cutaneous sensation caused by synthetic pyrethroids [abstract]. Clin Res 1982; 30: 915aGoogle Scholar
  81. 81.
    Knox JM, Tucker SB, Flannigan SA. Paresthesia from cutaneous exposure to a synthetic pyrethroid insecticide. Arch Dermatol 1984; 120: 744–6PubMedCrossRefGoogle Scholar
  82. 82.
    Flannigan SA, Tucker SB. Variation in cutaneous sensation between synthetic pyrethroid insecticides. Contact Dermatitis 1985; 13: 140–7PubMedCrossRefGoogle Scholar
  83. 83.
    Wang S, Zheng Q, Yu L, et al. Health survey among farmers exposed to deltamethrin in the cotton fields. Ecotoxicol Environ Saf 1988; 15: 1–6PubMedCrossRefGoogle Scholar
  84. 84.
    Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy 2005; 25: 448–50PubMedCrossRefGoogle Scholar
  85. 85.
    Kolmodin-Hedman B, Swensson Å, Åkerblom M. Occupational exposure to some synthetic pyrethroids (permethrin and fenvalerate). Arch Toxicol 1982; 50: 27–33PubMedCrossRefGoogle Scholar
  86. 86.
    Brandenburg K, Deinard AS, DiNapoli J, et al. 1% permethrin cream rinse vs 1% lindane shampoo in treating pediculosis capitis. Am J Dis Child 1986; 140: 894–6PubMedGoogle Scholar
  87. 87.
    Kalter DC, Sperber J, Rosen T, et al. Treatment of pediculosis pubis: clinical comparison of efficacy and tolerance of 1% lindane shampoo vs 1% permethrin creme rinse. Arch Dermatol 1987; 123: 1315–9PubMedCrossRefGoogle Scholar
  88. 88.
    International Programme on Chemical Safety. Environmental health criteria 94. Permethrin. Geneva: World Health Organization, 1990Google Scholar
  89. 89.
    Kolmodin-Hedman B, Åkerblom M, Flato S, et al. Symptoms in forestry workers handling conifer plants treated with permethrin. Bull Environ Contam Toxicol 1995; 55: 487–93PubMedCrossRefGoogle Scholar
  90. 90.
    DiNapoli JB, Austin RD, Englender SJ, et al. Eradication of head lice with a single treatment. Am J Public Health 1988; 78: 978–80PubMedCrossRefGoogle Scholar
  91. 91.
    Lisi P. Sensitization risk of pyrethroid insecticides. Contact Dermatitis 1992; 26: 349–50PubMedCrossRefGoogle Scholar
  92. 92.
    Müller-Mohnssen H. Chronic sequelae and irreversible injuries following acute pyrethroid intoxication. Toxicol Lett 1999; 107: 161–76PubMedCrossRefGoogle Scholar
  93. 93.
    Wagner SL. Allergy from pyrethrin or pyrethroid insecticides. J Agromed 1994; 1: 39–45CrossRefGoogle Scholar
  94. 94.
    Choudhary S. Burns due to anti-lice lotion. Burns 1999; 25: 184–5PubMedGoogle Scholar
  95. 95.
    Burns JD, Muller LT, Jenkins PF, et al. Unilateral mydriasis associated with exposure to flea spray. Arch Ophthalmol 2002; 120: 665PubMedGoogle Scholar
  96. 96.
    Miyamoto J. Degradation, metabolism and toxicity of synthetic pyrethroids. Environ Health Perspect 1976; 14: 15–28PubMedCrossRefGoogle Scholar
  97. 97.
    Moretto A. Indoor spraying with the pyrethroid insecticide lambda-cyhalothrin: effects on spraymen and inhabitants of sprayed houses. Bull World Health Organ 1991; 69: 591–4PubMedGoogle Scholar
  98. 98.
    Lessenger JE. Five office workers inadvertently exposed to cypermethrin. J Toxicol Environ Health 1992; 35: 261–7PubMedCrossRefGoogle Scholar
  99. 99.
    Fuortes L. Urticaria due to airborne permethrin exposure. Vet Hum Toxicol 1999; 41: 92–3PubMedGoogle Scholar
  100. 100.
    Newton JG, Breslin ABX. Asthmatic reactions to a commonly used aerosol insect killer. Med J Aust 1983; 1: 378–80PubMedGoogle Scholar
  101. 101.
    Vandenplas O, Delwiche JP, Auverdin J, et al. Asthma to tetramethrin. Allergy 2000; 55: 417–8PubMedCrossRefGoogle Scholar
  102. 102.
    Karpati AM, Perrin MC, Matte T, et al. Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000. Environ Health Perspect 2004; 112: 1183–7PubMedCrossRefGoogle Scholar
  103. 103.
    Bradley K, Cox R. Acute upper-airway obstruction in a two-year-old child who ingested an herbicide preparation. J Miss State Med Assoc 2004; 45: 98–101PubMedGoogle Scholar
  104. 104.
    Yang P-Y, Lin J-L, Hall AH, et al. Acute ingestion poisoning with insecticide formulations containing the pyrethroid permethrin, xylene, and surfactant: a review of 48 cases. J Toxicol Clin Toxicol 2002; 40: 107–13PubMedCrossRefGoogle Scholar
  105. 105.
    Grant SMB. An unusual case of burning mouth sensation. Br Dent J 1993; 175: 378–80PubMedCrossRefGoogle Scholar
  106. 106.
    Hou D. Pesticide ‘Decis’ induced massive hemorrhage of gastric intestinal tract [abstract]. Chin J Dig Dis 1986; 2: 116Google Scholar
  107. 107.
    Poisindex. Pyrethroids. In: POISINDEX® managements. Greenwood Village (CO): Micromedex, 2005Google Scholar
  108. 108.
    Terzi C, Bacakoglu A, Ünek T, et al. Chemical necrotizing fasciitis due to household insecticide injection: is immediate radical surgical debridement necessary? Hum Exp Toxicol 2002; 21: 687–90PubMedCrossRefGoogle Scholar
  109. 109.
    LoVecchio F, Knight J. Injection of pyrethroids without significant sequelae. Am J Emerg Med 2005; 23: 406PubMedCrossRefGoogle Scholar
  110. 110.
    Garg P, Garg P. Mosquito coil (allethrin) poisoning in two brothers. Indian Pediatr 2004; 41: 1177–8PubMedGoogle Scholar
  111. 111.
    Berthier F, Orrillard M, Blanchard M, et al. Intoxication par un insecticide: la deltamethrine. JEUR 1995; 8: 25–8Google Scholar
  112. 112.
    Poulos L, Athanaselis S, Coutselinis A. Acute intoxication with cypermethrin (NRDC 149). J Toxicol Clin Toxicol 1982; 19: 519–20PubMedCrossRefGoogle Scholar
  113. 113.
    O’Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet 1997; 349: 1161–6PubMedCrossRefGoogle Scholar
  114. 114.
    Box SA, Lee MR. A systemic reaction following exposure to a pyrethroid insecticide. Hum Exp Toxicol 1996; 15: 389–90PubMedCrossRefGoogle Scholar
  115. 115.
    Pall HS, Williams AC, Waring R, et al. Motorneurone disease as manifestation of pesticide toxicity. Lancet 1987; II: 685CrossRefGoogle Scholar
  116. 116.
    He F. Health surveillance of pesticide workers: a manual for occupational health professionals. Toxicology 1994; 91: 43–9PubMedCrossRefGoogle Scholar
  117. 117.
    Vijverberg HPM, van den Bercken J. Neurotoxicological effects and the mode of action of pyrethroid insecticides. Crit Rev Toxicol 1990; 21: 105–26PubMedCrossRefGoogle Scholar
  118. 118.
    Tucker SB, Flannigan SA, Ross CE. Inhibition of cutaneous paresthesia resulting from synthetic pyrethroid exposure. Int J Dermatol 1984; 23: 686–9PubMedCrossRefGoogle Scholar
  119. 119.
    Flannigan SA, Tucker SB, Key MM, et al. Synthetic pyrethroid insecticides: a dermatological evaluation. Br J Ind Med 1985; 42: 363–72PubMedGoogle Scholar
  120. 120.
    Advisory Committee on Pesticides. Evaluation number 55: esfenvalerate. London: Ministry of Agriculture Fisheries and Food, 1992Google Scholar
  121. 121.
    Song J-H, Narahashi T. Selective block of tetramethrin-modified sodium channels by (+/−)-alpha-tocopherol (vitamin E). J Pharmacol Exp Ther 1995; 275: 1402–11PubMedGoogle Scholar
  122. 122.
    Flannigan SA, Tucker SB. Topical indomethacin for synthetic pyrethroid exposure. Contact Dermatitis 1984; 11: 55–6PubMedCrossRefGoogle Scholar
  123. 123.
    Salawu OA, Iyaniwura TT, Adaudi AO. Effects of anticonvulsants on acute cypermethrin poisoning in mice and rats. Vet Hum Toxicol 2000; 42: 303–5PubMedGoogle Scholar
  124. 124.
    Hiromori T, Nakanashi T, Kawaguchi S, et al. Therapeutic effects of methocarbamol on acute intoxication by pyrethroids in rats. J Pestic Sci 1986; 11: 9–14CrossRefGoogle Scholar
  125. 125.
    Leclercq M, Cotonat J, Foulhoux P. Recherche d’un antagonisme à l’intoxication par la deltaméthrine. J Toxicol Clin Exp 1986; 6: 85–93PubMedGoogle Scholar
  126. 126.
    Matsumoto K, Eldefrawi ME, Eldefrawi AT. Action of polychlorocycloalkane insecticides on binding of (35S)t-butylbicyclophosphorothionate to Torpedo electric organ membranes and stereospecificity of the binding site. Toxicol Appl Pharmacol 1988; 95: 220–9PubMedCrossRefGoogle Scholar
  127. 127.
    Forshaw PJ, Ray DE. Development of therapy for type II pyrethroid insecticide poisoning [abstract]. Hum Exp Toxicol 1997; 16: 382Google Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Sally M. Bradberry
    • 1
  • Sarah A. Cage
    • 1
  • Alex T. Proudfoot
    • 1
  • J. Allister Vale
    • 1
  1. 1.City HospitalNational Poisons Information Service (Birmingham Centre)BirminghamUK

Personalised recommendations